Viral titer measurement


Viral titer measurment
A fast, easy and accurate determination of infectious viral titer.
RT assay kits designed for many common viral types
In an assay, specificity is the key to success. Each of the kits in the Cavidi catalog is designed for a specific viral type, and tested against that type. The range of kits covers a large fraction of the common applications of retroviruses for research purposes.
Accurate infectious titer measurement is critical Many experimental procedures in virology or immunology depend either on quantitation of the interaction between virus and host, or control of the interaction. Examples include development of passive immunotherapeutics, cloning a gene using a viral vector, or studying the effects of gene knock down using viruses as control elements. In these and many other cases, inaccurate determination of infectious viral titer can lead to highly erroneous results.
Reverse Transcriptase (RT) is the best proven method Over the years, a number of methods have been developed to measure infectious viral titer. Some are relatively inaccurate, but easy to do. Others are very accurate, but time consuming and resource intensive. Among the available methods, the determination of Reverse Transcriptase activity has emerged as the single method that is fast, easy and accurate. The problem is setting up the assay and validating it.
Cavidi kits bring convenience and reliability to the routine use of RT assay Until recently, commercial kits have not been available to meet the need for RT assays. Cavidi now offers a range of kits that make the routine use of RT assays convenient and reliable. The kits are designed specifically for their target viruses and rigorously tested, so that the user may place complete trust in the results.
RT assay kits designed for many common viral types In an assay, specificity is the key to success. Each of the kits in the Cavidi catalog is designed for a specific viral type, and tested against that type. The range of kits covers a large fraction of the common applications of retroviruses for research purposes.
Clinical products in development
Contact
- +46 18 55 20 40
- info@cavidi.se
- Virdings allé 16, 754 50 Uppsala